NEW DELHI: The central drug regulator has issued a notice of proven cause to the Serum Institute of India (SII) for not informing it about the pharmaceutical giant AstraZeneca that is pausing clinical trials of the Oxford vaccine candidate for Covid-19 in other countries and also for not presenting an …
Read More »LAC Showdown: India and China hope to back off in likely meeting | India News
Stock Photo NEW DELHI: India and China will seek to withdraw from the brink of military conflict in a likely meeting between Foreign Minister S Jaishankar and its Chinese counterpart Wang Yi on SCO margins in Moscow Thursday. While the Chinese Foreign Ministry did not confirm the meeting at its …
Read More »Deadlock in LAC: India Will Retaliate Should China Violate Red Lines, Says Senior Official | India News
NEW DELHI: Warning China of “ necessary retaliation ” if the red lines are now broken in eastern Ladakh, a senior government official said Wednesday that India has further strengthened its forward positions to counter new military build-ups Chinese and threatening movements in high places. altitude region. The warning comes …
Read More »Covid-19: Serum receives notice to continue vaccine trials | India News
NEW DELHI: India’s central drug regulator issued a notice to the Pune-based Serum Institute of India (SII) on Wednesday, asking why the company had failed to inform it of the “reported serious adverse events” that led to UK partner AstraZeneca to “temporarily pause” global clinical trials of the Oxford Covid …
Read More »India reports 74,894 recoveries in the last 24 hours, recovery rate at 77.77% | India News
NEW DELHI: With 74,894 reported recoveries in the past 24 hours, India’s recovery rate is now 77.77 percent, the Union Ministry of Health and Family Welfare (MoHFW) reported on Wednesday. “A total of 33,98,844 Covid-19 patients have recovered so far. The total number of weekly recoveries has increased from 1,53,118 …
Read More »Kangana Problem: Why Hindi? Poser by Jayant Patil for Fadnavis | India News
MUMBAI: Maharashtra CPN chief Jayant Patil criticized BJP leader on Wednesday Devendra Fadnavis after the latter pointed to the state government in Hindi about the partial demolition of actress Kangana Ranaut’s bungalow by the Mumbai civic body. By tagging Fadnavis on Twitter, Patil sought to know why the former chose …
Read More »Covid Summary: Human Trial of Oxford Vaccine Stopped; India’s recovery rate rises to 77.77% and more | India News
NEW DELHI: The number of people who have recovered from coronavirus infection in the country has risen to about 34 lakh, further improving the recovery rate to nearly 78 percent. Meanwhile, the quest to develop a vaccine for the virus ran into a minor hurdle when one of the participants …
Read More »Do not allow transgressions, maintain the maximum discipline: the Army instructs the ground commanders | India News
NEW DELHI: Engaged in a confrontation with the Chinese army, the Indian army it has instructed the field commanders that the Chinese should not be allowed to transgress at any cost and has also ordered the troops to maintain absolute discipline while protecting Indian territory. Field commanders have also been …
Read More »“Express Regret”: Kerala Opposition Leader Chennithala Withdraws Comment | India News
File photo of Kerala opposition leader Ramesh Chennithala THIRUVANANTHAPURAM: Kerala opposition leader Ramesh Chennithala on Wednesday he withdrew his comment asking “if only the Federation of Young Democratic Indians (DYFI) activists could harass women “and expressed regret for this. “My words, even if misinterpreted and taken out of context, should …
Read More »Demolition at Kangana Ranaut’s house Maharashtra government vendetta policy: BJP | India News
MUMBAI: On Wednesday, the BJP lashed out at the Shiv Sena-led MVA dispensation for the demolition of “illegal alterations” in the actress’s bungalow. Kangana Ranaut by the Mumbai civic body, calling the development a “politics of vendetta” and a kind of “government sponsored terror” in the state. Opposition leader in …
Read More »